Entities / Company
Regulus Therapeutics.
Biopharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 11
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Regulus Therapeutics this week
News at the entities that move Regulus Therapeutics most-
Novartis StructuralNovartis developed a Bruton's tyrosine kinase inhibitor, with Heinz Wiendl being a professor at the University of Freiburg.Moves Regulus Therapeutics
Connections
The 1 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Novartis Structural
Novartis acquired Regulus Therapeutics, establishing it as a subsidiary to expand its biopharmaceutical portfolio.